Breaking News Instant updates and real-time market news.

2020-04-22 20:24:27 TW Tradeweb Markets $51.08 / -0.58 (-1.12%) 20:24 04/22/20 04/22 20:24 04/22/20 20:24	Tradeweb Markets 11.16M share Secondary priced at $50.25 The deal size was increased from 10.95M shares and priced below the last closing price of $51.25. JPMorgan, Barclays, Citi, Goldman Sachs and Morgan Stanley are acting as joint book running managers for the offering.	07 May 19 May 23 Apr
TW Tradeweb Markets $51.08 / -0.58 (-1.12%) 04/21/20 Rosenblatt Tradeweb Markets' set-up remains attractive, says Rosenblatt 12/16/19 Credit Suisse Tradeweb Markets upgraded to Outperform from Neutral at Credit Suisse 11/20/19 Fly Intel: Top five analyst upgrades 11/20/19 Goldman Sachs Cboe Global Markets downgraded to Neutral from Conviction Buy at Goldman Sachs

2020-04-22 20:24:27

Tradeweb Markets

$51.08 / -0.58 (-1.12%)

20:24

04/22/20

04/22

20:24

04/22/20

20:24

Tradeweb Markets 11.16M share Secondary priced at $50.25

The deal size was increased from 10.95M shares and priced below the last closing price of $51.25. JPMorgan, Barclays, Citi, Goldman Sachs and Morgan Stanley are acting as joint book running managers for the offering.

07
May
19
May

23
Apr

TW Tradeweb Markets

$51.08 / -0.58 (-1.12%)

04/21/20 Rosenblatt: Tradeweb Markets' set-up remains attractive, says Rosenblatt

12/16/19 Credit Suisse: Tradeweb Markets upgraded to Outperform from Neutral at Credit Suisse

11/20/19: Fly Intel: Top five analyst upgrades

11/20/19 Goldman Sachs: Cboe Global Markets downgraded to Neutral from Conviction Buy at Goldman Sachs

TODAY'S FREE FLY STORIES

Options	Nordstrom put volume heavy and directionally bearish » 11:35 04/23/21 04/23 11:35 04/23/21 11:35 JWN Nordstrom $37.25 / +0.43 (+1.17%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JWN Nordstrom $37.25 / +0.43 (+1.17%) 03/02/21 Nordstrom says overall trends improved sequentially throughout the quarter 03/02/21 Nordstrom says taking actions to 'significantly reduce inventory levels' in Q1 03/02/21 Nordstrom says Q4 digital sales of about $2B represented 54% of business 03/01/21 Nordstrom, Tonal form partnership JWN Nordstrom $37.25 / +0.43 (+1.17%) 03/12/21 Fly Intel: Top five analyst initiations 03/12/21 Jefferies Jefferies picks Macy's, Kohl's and Nordstrom as department store 'survivors' 03/12/21 Jefferies Nordstrom initiated with a Buy at Jefferies 02/16/21 JPMorgan Nordstrom price target raised to $40 from $34 at JPMorgan JWN Nordstrom $37.25 / +0.43 (+1.17%) 03/02/21 Nordstrom sees FY21 revenue up more than 25%, consensus $13.46B 03/02/21 Nordstrom reports Q4 EPS 21c, consensus 14c 03/02/21 Nordstrom reports Q4 EPS 21c, consensus 14c 02/04/21 Nordstrom gives long-term outlook, sees sales growing low single-digits annually JWN Nordstrom $37.25 / +0.43 (+1.17%) 01/02/21 Nordstrom looks like a department store survivor, Barron's says JWN Nordstrom $37.25 / +0.43 (+1.17%) 03/12/21 Lennar downgrade, Barclays upgrade among today's top calls on Wall Street 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: After-Hours Movers 05/19/21 Nordstrom Inc. JWN Nordstrom $37.25 / +0.43 (+1.17%) 04/16/21 Nordstrom put volume heavy and directionally bearish 04/15/21 Nordstrom put volume heavy and directionally bearish 03/24/21 Nordstrom put volume heavy and directionally bearish 03/02/21 Nordstrom options imply 13.1% move in share price post-earnings
Recommendations	Summit Industrial Income price target raised to C$17 from C$16 at National Bank » 11:34 04/23/21 04/23 11:34 04/23/21 11:34 SMMCF Summit Industrial Income REIT $12.51 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SMMCF Summit Industrial Income REIT $12.51 / + (+0.00%) 04/22/21 Raymond James Summit Industrial price target raised to C$17 from C$15.75 at Raymond James 03/24/21 Raymond James Summit Industrial Income REIT initiated with an Outperform at Raymond James 02/23/21 Scotiabank Summit Industrial price target raised to C$15.50 from C$14.25 at Scotiabank 02/19/21 RBC Capital Summit Industrial Income REIT price target raised to C$15.50 from C$14.50 at RBC Capital
Recommendations	WPT Industrial price target raised to C$18.50 from C$17.50 at National Bank » 11:34 04/23/21 04/23 11:34 04/23/21 11:34 WPTIF WPT Industrial REIT $16.76 / +0.11 (+0.66%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research WPTIF WPT Industrial REIT $16.76 / +0.11 (+0.66%) 03/29/21 WPT Industrial REIT contributes $370M portfolio to new joint venture WPTIF WPT Industrial REIT $16.76 / +0.11 (+0.66%) 03/12/21 BMO Capital WPT Industrial REIT price target raised to C$16 from C$14.75 at BMO Capital 03/12/21 Raymond James WPT Industrial REIT price target raised to C$16.75 from C$16 at Raymond James 01/22/21 National Bank WPT Industrial REIT price target raised to $17.50 from $15.50 at National Bank 11/16/20 BMO Capital WPT Industrial price target raised to C$14.75 from C$14.25 at BMO Capital
Recommendations	Sienna Senior Living price target raised to C$16 from C$15 at National Bank » 11:33 04/23/21 04/23 11:33 04/23/21 11:33 LWSCF Sienna Senior Living $11.55 / -0.08 (-0.69%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research LWSCF Sienna Senior Living $11.55 / -0.08 (-0.69%) 01/25/21 Sienna Senior Living says rent collection levels remain 'at and above' 99% 01/25/21 Sienna Senior Living: 75% of long-term care residents vaccinated as of Jan. 22 LWSCF Sienna Senior Living $11.55 / -0.08 (-0.69%) 02/22/21 RBC Capital Sienna Senior Living price target raised to C$14 from C$13 at RBC Capital 11/19/20 Scotiabank Sienna Senior Living price target raised to C$15 from C$13 at Scotiabank 11/16/20 BMO Capital Sienna Senior Living price target lowered to C$14.25 at BMO Capital 11/13/20 Canaccord Sienna Senior Living price target raised to C$12.75 from C$11 at Canaccord
Recommendations	RioCan REIT price target raised to C$22 from C$21 at National Bank » 11:33 04/23/21 04/23 11:33 04/23/21 11:33 RIOCF RioCan REIT $16.39 / -0.03 (-0.18%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RIOCF RioCan REIT $16.39 / -0.03 (-0.18%) 04/01/21 RioCan REIT completes CEO transition to Jonathan Girlin 03/24/21 RioCan REIT, Allied execute leases for approx. 110,000 sq. ft. at The Well 03/11/21 RioCan REIT appoints Andrew Duncan as CIO 03/02/21 RioCan REIT CFO Qi Tang to depart RIOCF RioCan REIT $16.39 / -0.03 (-0.18%) 03/29/21 Canaccord RioCan REIT price target raised to C$20 from C$18 at Canaccord 02/12/21 Canaccord RioCan REIT price target raised to C$18 from C$17.50 at Canaccord 11/02/20 BMO Capital RioCan REIT price target lowered to C$17 from C$18.50 at BMO Capital 10/30/20 Canaccord RioCan REIT price target lowered to C$17.50 from C$18.25 at Canaccord RIOCF RioCan REIT $16.39 / -0.03 (-0.18%) 10/29/20 RioCan REIT reports Q3 FFO C0.41 vs. C0.47 last year

Recommendations	Invesque price target raised to C$3 from C$2.75 at National Bank » 11:32 04/23/21 04/23 11:32 04/23/21 11:32 MHIVF Invesque $3.04 / -0.04 (-1.30%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research MHIVF Invesque $3.04 / -0.04 (-1.30%) 03/26/21 BMO Capital Invesque downgraded to Market Perform from Outperform at BMO Capital 03/26/21 BMO Capital Invesque downgraded to Market Perform from Outperform at BMO Capital
Recommendations	First Capital REIT price target raised to C$18.50 from C$16.50 at National Bank » 11:31 04/23/21 04/23 11:31 04/23/21 11:31 FCXXF First Capital REIT $13.85 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FCXXF First Capital REIT $13.85 / + (+0.00%) 03/29/21 Canaccord First Capital REIT price target raised to C$18.65 from C$17.25 at Canaccord 08/07/20 CIBC First Capital REIT upgraded to Outperformer from Neutral at CIBC
Syndicate	Agiliti opens at $16.05, IPO priced at $14 per share 11:31 04/23/21 04/23 11:31 04/23/21 11:31 AGTI Agiliti $10.51 / + (+0.00%) ShowHide Related Items >><< Syndicate 23 Apr
Recommendations	Choice Properties price target raised to C$14.50 from C$13.50 at National Bank » 11:30 04/23/21 04/23 11:30 04/23/21 11:30 PPRQF Choice Properties REIT $11.33 / + (+0.00%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PPRQF Choice Properties REIT $11.33 / + (+0.00%) 02/17/21 Scotiabank Choice Properties REIT price target raised to C$14 from C$13.50 at Scotiabank 02/12/21 CIBC Choice Properties REIT price target raised to C$14 from C$13.50 at CIBC 11/13/20 Scotiabank Choice Properties price target raised to C$13.50 from C$12.50 at Scotiabank 11/06/20 BMO Capital Choice Properties REIT price target raised to C$13.50 from C$13 at BMO Capital
Recommendations	Extendicare price target raised to C$8 from C$7 at National Bank » 11:30 04/23/21 04/23 11:30 04/23/21 11:30 EXETF Extendicare $6.11 / +0.0105 (+0.17%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EXETF Extendicare $6.11 / +0.0105 (+0.17%) 03/01/21 National Bank Extendicare price target raised to C$7 from C$6.60 at National Bank 01/22/21 National Bank Extendicare price target lowered to C$6.50 from C$7 at National Bank 11/19/20 National Bank Extendicare price target raised to C$7 from C$6 at National Bank 08/18/20 RBC Capital Extendicare price target lowered to C$7 from C$7.50 at RBC Capital

Recommendations	Crombie REIT price target raised to C$17 from C$16.50 at National Bank » 11:29 04/23/21 04/23 11:29 04/23/21 11:29 CROMF Crombie REIT $12.90 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CROMF Crombie REIT $12.90 / + (+0.00%) 04/21/21 CIBC Crombie REIT price target raised to C$16.75 from C$16.25 at CIBC 03/29/21 Canaccord Crombie REIT price target raised to C$16 from C$15.50 at Canaccord 03/02/21 Desjardins Crombie REIT price target raised to C$16 from C$15.50 at Desjardins 03/01/21 BMO Capital Crombie REIT price target raised to C$15.50 from C$14.50 at BMO Capital
Recommendations	SmartCentres price target raised to C$29 from C$27 at National Bank » 11:28 04/23/21 04/23 11:28 04/23/21 11:28 CWYUF SmartCentres $22.50 / -0.109 (-0.48%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CWYUF SmartCentres $22.50 / -0.109 (-0.48%) 02/16/21 TD Securities SmartCentres price target raised to C$26 from C$25 at TD Securities 02/16/21 BMO Capital SmartCentres price target raised to C$23.50 from C$22 at BMO Capital 02/12/21 Canaccord SmartCentres upgraded to Buy from Hold at Canaccord 01/22/21 National Bank SmartCentres price target lowered to C$25 from C$26 at National Bank
Options	Bilibili call volume above normal and directionally bullish » 11:25 04/23/21 04/23 11:25 04/23/21 11:25 BILI Bilibili $113.82 / +5.73 (+5.30%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BILI Bilibili $113.82 / +5.73 (+5.30%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal BILI Bilibili $113.82 / +5.73 (+5.30%) 04/19/21 CLSA Bilibili initiated with a Buy, $128 target at CLSA 04/08/21 Fly Intel: Top five analyst upgrades 04/08/21 Credit Suisse Bilibili upgraded to Outperform at Credit Suisse after recent pullback 04/08/21 Credit Suisse Bilibili upgraded to Outperform from Neutral at Credit Suisse BILI Bilibili $113.82 / +5.73 (+5.30%) 02/24/21 Bilibili sees Q1 revenue RMB3.7B-RMB3.8B 02/24/21 Bilibili reports Q4 adjusted EPS (29c), consensus (33c) 11/18/20 Bilibili reports Q3 EPS (41c), consensus (37c) BILI Bilibili $113.82 / +5.73 (+5.30%) 03/22/21 Bilibili set to raise $2.6B in Hong Kong listing, Bloomberg reports 02/16/21 ByteDance looks to list Douyin in NY as Biden sets new mood, SCMP reports BILI Bilibili $113.82 / +5.73 (+5.30%) 04/08/21 Adobe coverage reinstatement, Carvana initiation among top calls on Wall Street 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 05/13/21 Bilibili - BILI BILI Bilibili $113.82 / +5.73 (+5.30%) 04/15/21 Bilibili call volume above normal and directionally bullish 03/26/21 Bilibili put volume heavy and directionally bearish 02/10/21 Bilibili call volume above normal and directionally bullish 02/05/21 Unusually active option classes on open February 5th
Conference/Events	Truist biotechnology analysts to hold an analyst/industry conference call » 11:25 04/23/21 04/23 11:25 04/23/21 11:25 BMY Bristol-Myers $66.34 / +0.02 (+0.03%) Biotechnology Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $66.34 / +0.02 (+0.03%) 10:03 Today Bristol-Myers says Phase 3 trials of deucravacitinib met co-primary endpoints 06:54 Today Bristol-Myers announces EMA's CHMP recommends approval of Onureg in Europe 06:47 Today Bristol-Myers announces EMA's CHMP recommends approval of Opdivo 04/16/21 Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer BMY Bristol-Myers $66.34 / +0.02 (+0.03%) 04/21/21 Citi Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data 04/21/21 Citi Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy 04/13/21 Truist Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility 04/13/21 Truist Bristol-Myers upgraded to Buy from Hold at Truist BMY Bristol-Myers $66.34 / +0.02 (+0.03%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $66.34 / +0.02 (+0.03%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $66.34 / +0.02 (+0.03%) 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11:00 Today Pharmaceuticals 12:00 Today Biotechnology 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $66.34 / +0.02 (+0.03%) 10:25 Today Bristol Myers Squibb call volume above normal and directionally bullish 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th
Periodicals	FactSet seen attracting takeover interest, Dealreporter says » 11:24 04/23/21 04/23 11:24 04/23/21 11:24 FDS FactSet $319.39 / -5.05 (-1.56%) FactSet (FDS) is expected… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FDS FactSet $319.39 / -5.05 (-1.56%) 04/20/21 FactSet appoints Helen Shan as CRO 04/05/21 JPX, FactSet announces plans for new thematic indices 03/08/21 FactSet launches Truvalue Labs SDG Monitor 03/04/21 FactSet, Ping An partner to offer investors ESG content, analytics FDS FactSet $319.39 / -5.05 (-1.56%) 03/30/21 Goldman Sachs FactSet price target raised to $276 from $263 at Goldman Sachs 03/24/21 DA Davidson FactSet may top consensus, affirm guidance with Q2 results, says DA Davidson 12/22/20 Morgan Stanley FactSet price target raised to $278 from $269 at Morgan Stanley 09/25/20 Deutsche Bank FactSet price target raised to $315 from $293 at Deutsche Bank FDS FactSet $319.39 / -5.05 (-1.56%) 03/30/21 FactSet sees FY21 adjusted EPS $10.75-$11.15, consensus $11.17 03/30/21 FactSet reports Q2 adjusted EPS $2.72, consensus $2.74 12/21/20 FactSet backs FY21 adjusted EPS view $10.75-$11.15, consensus $11.04 12/21/20 FactSet reports Q1 adjusted EPS $2.88, consensus $2.75 05/06/21 3rd Annual eXtreme Services Virtual Conference

Recommendations	Canadian Apartment Properties price target raised to C$65 at National Bank » 11:21 04/23/21 04/23 11:21 04/23/21 11:21 CDPYF Canadian Apartment Properties $44.23 / -0.21 (-0.47%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CDPYF Canadian Apartment Properties $44.23 / -0.21 (-0.47%) 03/01/21 RBC Capital Canadian Apartment Properties price target raised to C$64 at RBC Capital 02/26/21 BMO Capital Canadian Apartment Properties price target raised to C$59 at BMO Capital 02/26/21 CIBC Canadian Apartment Properties price target raised to C$56 from C$52 at CIBC 02/26/21 National Bank Canadian Apartment Properties price target raised to C$62 at National Bank
Periodicals	SVF Investment Corp. 3 in talks to bring Mapbox public, Sky News says » 11:18 04/23/21 04/23 11:18 04/23/21 11:18 SVFC SVF Investment Corp. 3 $10.58 / +0.38 (+3.73%) , SFTBY SoftBank $46.20 / -0.55 (-1.18%) SVF Investment Corp. 3… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events SFTBY SFTBY SoftBank $46.20 / -0.55 (-1.18%) 04/19/21 U.K. opens investigation into Nvidia acquisition of Arm business 04/19/21 UK launches national security probe into Nvidia's takeover of ARM 04/13/21 Televisa, Univision agree to combine content, production assets 04/07/21 SoftBank's Vision Fund 2, BlackRock lead $640M funding in Trax SVFC SFTBY SVFC SVF Investment Corp. 3 $10.58 / +0.38 (+3.73%) SFTBY SoftBank $46.20 / -0.55 (-1.18%) 04/20/21 Citi Nvidia deal for Arm has only 10% chance of closing, says Citi 03/11/21 Jefferies SoftBank downgraded to Hold from Buy at Jefferies 03/10/21 Morgan Stanley SoftBank resumed with an Equal Weight at Morgan Stanley 11/27/20 Citi SoftBank price target raised to 11,000 yen from 10,200 yen at Citi SFTBY SFTBY SoftBank $46.20 / -0.55 (-1.18%) 04/19/21 SoftBank in discussions to lead $100M financing round in Whatfix, ET reports 04/15/21 SoftBank to potentially invest up to $500M in Swiggy, TechCrunch reports 04/08/21 SoftBank invests $500M in Better, brings valuation to about $6B, WSJ says 04/05/21 SoftBank approaches deal to take 40% stake in AutoStore, WSJ reports SVFC SFTBY SVFC SVF Investment Corp. 3 $10.58 / +0.38 (+3.73%) 03/14/21 Opening Day: Coupang, Roblox soar in market debuts SFTBY SoftBank $46.20 / -0.55 (-1.18%) 04/04/21 On the Fly: The Week in SPAC News 04/03/21 Opening Day: Softbank-backed Compass raises $450M in IPO 03/28/21 On the Fly: The Week in SPAC News 03/21/21 On the Fly: The Week in SPAC News 05/12/21 SoftBank - SFTBY
Technical Analysis	NASDAQ market internals summary » 11:17 04/23/21 04/23 11:17 04/23/21 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 04/22/21 NASDAQ market internals summary 04/22/21 NASDAQ market internals summary 04/22/21 NASDAQ market internals summary
Recommendations	SilverCrest Metals price target raised to C$14.50 from C$14 at National Bank » 11:16 04/23/21 04/23 11:16 04/23/21 11:16 SILV SilverCrest Metals $8.77 / -0.05 (-0.57%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Options SILV SilverCrest Metals $8.77 / -0.05 (-0.57%) 02/02/21 SilverCrest Metals announces positive feasibility study results for Las Chispas SILV SilverCrest Metals $8.77 / -0.05 (-0.57%) 02/24/21 BMO Capital SilverCrest Metals resumed with an Outperform at BMO Capital 02/08/21 Stifel SilverCrest Metals price target lowered to C$15.50 from C$16 at Stifel 02/04/21 National Bank SilverCrest Metals price target lowered to C$17.25 from C$19 at National Bank 02/04/21 Stifel SilverCrest Metals upgraded to Buy after Las Chispas study at Stifel 12 Feb SILV SilverCrest Metals $8.77 / -0.05 (-0.57%) 02/01/21 Unusually active option classes on open February 1st
Technical Analysis	NYSE market internals summary » 11:16 04/23/21 04/23 11:16 04/23/21 11:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 04/22/21 NYSE market internals summary 04/22/21 NYSE market internals summary 04/22/21 NYSE market internals summary

Recommendations	Marathon Gold price target raised to C$3.50 from C$3.25 at National Bank » 11:15 04/23/21 04/23 11:15 04/23/21 11:15 MGDPF Marathon Gold $2.09 / -0.05 (-2.34%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research MGDPF Marathon Gold $2.09 / -0.05 (-2.34%) 04/21/21 Marathon Gold reports maiden mineral resource estimate for Berry Deposit 04/06/21 Marathon Gold reports additional Berry drill results 03/11/21 Marathon Gold reports first 2021 exploration drill results from Valentine Gold 02/02/21 Marathon Gold announces fire assay data from program at Valentine Gold Project MGDPF Marathon Gold $2.09 / -0.05 (-2.34%) 04/06/21 Scotiabank Marathon Gold price target raised to C$3.50 from C$3.25 at Scotiabank 03/31/21 CIBC Marathon Gold price target lowered to C$3.75 from C$4 at CIBC 03/31/21 TD Securities Marathon Gold price target lowered to C$4 from C$4.25 at TD Securities 01/15/21 Raymond James Marathon Gold price target raised to C$3.50 from C$2.85 at Raymond James
Recommendations	Maverix Metals price target raised to C$7.75 from C$7.50 at National Bank » 11:15 04/23/21 04/23 11:15 04/23/21 11:15 MMX Maverix Metals $5.76 / +0.04 (+0.70%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate MMX Maverix Metals $5.76 / +0.04 (+0.70%) 02/16/21 Maverix sees FY21 attributable gold equivalent ounces 27,000-30,000 02/16/21 Maverix reports Q4 record gold equivalent ounces sold up 25% from last year MMX Maverix Metals $5.76 / +0.04 (+0.70%) 04/21/21 Canaccord Maverix Metals downgraded to Hold from Buy at Canaccord 02/03/21 Raymond James Maverix Metals price target lowered to C$8.25 from C$8.50 at Raymond James 01/11/21 National Bank Maverix Metals price target raised to C$8 from C$7.75 at National Bank 09/24/20 National Bank Maverix Metals price target raised to C$7.75 from C$7.50 at National Bank 29 May
Recommendations	Franco-Nevada price target raised to C$190 from C$185 at National Bank » 11:14 04/23/21 04/23 11:14 04/23/21 11:14 FNV Franco-Nevada $141.99 / +0.35 (+0.25%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options FNV Franco-Nevada $141.99 / +0.35 (+0.25%) 03/10/21 Franco-Nevada raises quarterly dividend to 30c from 26c per share 11/04/20 Franco-Nevada provides 2020 guidance FNV Franco-Nevada $141.99 / +0.35 (+0.25%) 04/20/21 BMO Capital Franco-Nevada price target raised to C$195 from C$193 at BMO Capital 03/12/21 National Bank Franco-Nevada price target lowered to C$205 from C$210 at National Bank 03/12/21 Barclays Franco-Nevada upgraded to Equal Weight from Underweight at Barclays 03/07/21 BMO Capital Franco-Nevada upgraded to Outperform from Market Perform at BMO Capital FNV Franco-Nevada $141.99 / +0.35 (+0.25%) 03/10/21 Franco-Nevada reports Q4 EPS 85c, consensus 27c 11/04/20 Franco-Nevada reports Q3 EPS 81c, consensus 27c FNV Franco-Nevada $141.99 / +0.35 (+0.25%) 03/10/21 Fly Intel: After-Hours Movers 05/06/21 Franco-Nevada - FNV FNV Franco-Nevada $141.99 / +0.35 (+0.25%) 02/01/21 Largest borrow rate increases among liquid names 11/18/20 Largest borrow rate increases among liquid names
Recommendations	Fortuna Silver Mines price target raised to C$12.50 at National Bank » 11:14 04/23/21 04/23 11:14 04/23/21 11:14 FSM Fortuna Silver Mines $7.66 / -0.02 (-0.26%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FSM Fortuna Silver Mines $7.66 / -0.02 (-0.26%) 04/15/21 Fortuna Silver Mines rises 9.0% 04/12/21 Fortuna Silver Mines produces 1.9M ounces of silver, 34.555 ounces of gold in Q1 02/01/21 Silver producers up in pre-market on r/wallstreetbets short squeeze speculation 01/28/21 Fortuna Silver Mines rises 20.4% FSM Fortuna Silver Mines $7.66 / -0.02 (-0.26%) 04/13/21 BMO Capital Fortuna Silver Mines price target raised to C$12.50 from C$12.25 at BMO Capital 03/29/21 BMO Capital Fortuna Silver Mines price target lowered to $12.75 from $13 at BMO Capital 03/11/21 BMO Capital Fortuna Silver Mines price target raised to C$13 from C$12 at BMO Capital 02/08/21 CIBC Fortuna Silver Mines price target lowered to C$11.25 from C$11.50 at CIBC FSM Fortuna Silver Mines $7.66 / -0.02 (-0.26%) 03/10/21 Fortuna Silver Mines reports Q4 EPS 10c, consensus 10c 11/13/20 Fortuna Silver Mines reports Q3 EPS 7c, consensus 10c FSM Fortuna Silver Mines $7.66 / -0.02 (-0.26%) 02/01/21 CME raises Silver futures margins by 18% to curb volatility, Bloomberg says FSM Fortuna Silver Mines $7.66 / -0.02 (-0.26%) 02/01/21 Fly Intel: Wall Street's top stories for Monday 02/01/21 Fly Intel: Wall Street's top stories at midday 11/13/20 Fly Intel: Pre-market Movers FSM Fortuna Silver Mines $7.66 / -0.02 (-0.26%) 02/01/21 Fortuna Silver Mines call volume above normal and directionally bullish 02/01/21 Unusually active option classes on open February 1st 01/28/21 Fortuna Silver Mines call volume above normal and directionally bullish 01/21/21 Fortuna Silver Mines call volume above normal and directionally bullish
Hot Stocks	Teva launches generic version of Casana suppositories » 11:10 04/23/21 04/23 11:10 04/23/21 11:10 TEVA Teva $10.11 / -0.095 (-0.93%) Teva Pharmaceuticals USA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TEVA Teva $10.11 / -0.095 (-0.93%) 04/19/21 Teva announces new data on efficacy of AJOVY 04/08/21 Teva receives EU Marketing Authorization for Seffalair Spiromax 03/31/21 CareDx announces new leadership appointments and promotions 03/08/21 Teva announces launch of generic version of Azopt 1% TEVA Teva $10.11 / -0.095 (-0.93%) 04/06/21 RBC Capital Teva transferred with a Sector Perform at RBC Capital 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 12/21/20 Gabelli Teva named 'Best Idea for 2021' at Gabelli 11/27/20 H.C. Wainwright Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright TEVA Teva $10.11 / -0.095 (-0.93%) 02/10/21 Teva sees Q1 lowest for EPS, sales in FY21 02/10/21 Teva sees FY21 EBITDA $4.8B-$5.1B 02/10/21 Teva sees FY21 EPS $2.50-$2.70, consensus $2.63 02/10/21 Teva reports Q4 EPS 68c, consensus 63c TEVA Teva $10.11 / -0.095 (-0.93%) 04/20/21 California lawyer accuses drugmakers of causing opioid addiction, WSJ reports 03/17/21 Biogen, Alkermes sue Teva to block MS drug, Bloomberg reports 02/10/21 CEO says Teva in discussions to co-produce COVID vaccine, Reuters reports 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports TEVA Teva $10.11 / -0.095 (-0.93%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday 04/28/21 Teva - TEVA TEVA Teva $10.11 / -0.095 (-0.93%) 09:55 Today Teva put volume heavy and directionally bearish 02/02/21 Teva call volume above normal and directionally bullish 01/19/21 Teva call volume above normal and directionally bullish 01/06/21 Notable open interest changes for January 6th

Events

Earnings calls, analyst events, roadshows and more

MYFW
Today at 12:00

First Western Financial - MYFW Conference Calls
SBSI
Today at 12:00

Southside Bancshares - SBSI Conference Calls
CSTR
Today at 12:00

CapStar Financial - CSTR Conference Calls
IONS
Today at 12:00

Ionis Pharmaceuticals - IONS Conference Calls
MOFG
Today at 12:00

MidWestOne - MOFG Conference Calls
BMY
Today at 12:00

Biotechnology Industry Meetings
CIVB
Today at 13:00

Civista Bancshares - CIVB Conference Calls
ACBI
Today at 13:00

Atlantic Capital - ACBI Conference Calls
WSFS
Today at 13:00

WSFS Financial - WSFS Conference Calls
FHB
Today at 13:00

First Hawaiian - FHB Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares IFBD X IFBD Infobird IPO Managers: WestPark Capital Priced at: $4.00 6.25M Shares
Tues	DV X DV DoubleVerify IPO Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, Truist, William Blair, KeyBanc, Canaccord, JMP Securities, Needham, Loop Capital, Capital One Priced at: $27.00 13.3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PATH X PATH UiPath IPO Managers: Morgan Stanley & JPMorgan, BofA, Credit Suisse, Barclays, Wells Fargo, SMBC Nikko, BMO Capital, MIZU, KeyBanc, TD Securities, Truist, Cowen, Evercore ISI, Macquarie, Nomura, RBC Capital, Canaccord, DA Davidson, Oppenheimer, Needham Priced at: $56.00 23.89M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SKYT X SKYT SkyWater Technology IPO Managers: Jefferies & Cowen, Piper Sandler Priced at: $14.00 6.96M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRKA X TRKA Troika Media IPO Managers: Kingswood Priced at: $4.15 5.78M Shares FUTU X FUTU Futu Holdings Secondary Managers: BofA & Haitong Priced at: $130.00 9.5M Shares ZLAB X ZLAB Zai Lab Secondary Managers: JPMorgan, Goldman Sachs, Jefferies, Citi, SVB Leerink & Guggenheim Priced at: $150.00 4.78M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NOTV X NOTV Inotiv Spot Secondary Managers: Colliers Priced at: $17.00 2.647M Shares
Wed	KNBE X KNBE KnowBe4 IPO Managers: Morgan Stanley, Goldman Sachs, BofA & KKR Priced at: $16.00 9.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NPCE X NPCE NeuroPace IPO Managers: JPMorgan & Morgan Stanley, Wells Fargo, SVB Leerink Priced at: $17.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZY X ZY Zymergen IPO Managers: JPMorgan & Goldman Sachs, BofA, UBS, LAZA Priced at: $31.00 16.13M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EOLS X EOLS Evolus Spot Secondary Managers: SVB Leerink, Stifel & Cantor Fitzgerald Priced at: $9.50 9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NBSE X NBSE NeuBase Therapeutics Spot Secondary Managers: RBC Capital, Oppenheimer & Chardan, National Securities Priced at: $5.00 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AGTI X AGTI Agiliti IPO Managers: BofA, Goldman Sachs, Morgan Stanley & BMO Capital, Citi, JEFF< UBSW, KeyBanc, Raymond James, MUFG, SMBC Nikko, MISC, SIEB Priced at: $14.00 26.316M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMPL X IMPL Impel NeuroPharma IPO Managers: Cowen & Guggenheim, Wedbush Priced at: $15.00 5.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RAIN X RAIN Rain Therapeutics IPO Managers: Goldman Sachs, Citi, Piper Sandler & Guggenheim Priced at: $17.00 7.353M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWIM X SWIM Latham Group IPO Managers: Barclays, BofA, Morgan Stanley & Goldman Sachs, Nomura, William Blair, Baird, KeyBanc, Truist Priced at: $19.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical IPO Managers: JPMorgan & Morgan Stanley, SVB Leerink, Stifel Priced at: $17.00 11.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDAP X EDAP EDAP TMS Spot Secondary Managers: Piper Sandler Priced at: $6.75 4.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Tradeweb Markets 11.16M share Secondary priced at $50.25

TODAY'S FREE FLY STORIES

Get Full Fly Access